By: AquaNab With sea lice costing the aquaculture industry an estimated USD 4 billion annually, the Hamburg-based company has developed AquaNabs, a first-of-its-kind nanoantibody treatment, delivered through fish feed, offering a sustainable alternative to conventional chemical and mechanical delousing. AquaNab, a Hamburg-based biotechnology company, is developing precision nanoantibody technology to treat and prevent sea lice, one of […]
German Biotech AquaNab Targets a USD 4 Billion Salmon Farming Problem with Nanoantibody Technology – Secures Funding to Combat Global Sea Lice Challenge
My Name